Johnson & Johnson (JNJ) Free Cash Flow (QoQ) (2009 - 2026)
Powered by 
Analysis
Johnson & Johnson (JNJ) Free Cash Flow (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 397.95% |
| Mar 29, 2026 | -73.23% |
| Dec 28, 2025 | -31.70% |
| Sep 28, 2025 | 182.61% |
| Jun 29, 2025 | -16.10% |
| Mar 30, 2025 | -37.09% |
| Dec 29, 2024 | -22.87% |
| Sep 29, 2024 | 49.54% |
| Jun 30, 2024 | 63.40% |
| Mar 31, 2024 | -54.57% |
| Dec 31, 2023 | -3.80% |
| Oct 1, 2023 | 113.28% |
| Jul 2, 2023 | 27.74% |
| Apr 2, 2023 | 37.27% |
| Oct 3, 2021 | 67.58% |
| Jul 4, 2021 | 32.50% |
| Apr 4, 2021 | -51.61% |
| Jan 3, 2021 | -8.19% |
| Sep 27, 2020 | 174.05% |
| Jun 28, 2020 | 2.09% |